Joel Greenblatt's BHC Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 57,024 shares of Bausch Health Companies Inc. (BHC) worth $367,805, representing 0.00% of the portfolio. First purchased in 2018-Q3, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in BHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2019, adding 223,822 shares. Largest reduction occurred in Q2 2020, reducing 103,304 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Bausch Health Companies (BHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bausch Health Companies (BHC) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2018 | +7,956 | New Buy | 7,956 | $25.64 |
| Q4 2018 | -7,956 | Sold Out | 7,956 | $0.00 |
| Q2 2019 | +231,778 | New Buy | 231,778 | $25.22 |
| Q3 2019 | -33,075 | Reduce 14.27% | 198,703 | $21.85 |
| Q4 2019 | -83,888 | Reduce 42.22% | 114,815 | $29.92 |
| Q1 2020 | -114,815 | Sold Out | 114,815 | $0.00 |
| Q2 2020 | +11,511 | New Buy | 11,511 | $18.33 |
| Q3 2020 | -11,511 | Sold Out | 11,511 | $0.00 |
| Q1 2021 | +21,108 | New Buy | 21,108 | $31.74 |
| Q2 2021 | -21,108 | Sold Out | 21,108 | $0.00 |
| Q4 2021 | +11,244 | New Buy | 11,244 | $27.57 |
| Q1 2022 | +6,915 | Add 61.50% | 18,159 | $22.85 |
| Q2 2022 | +82,735 | Add 455.61% | 100,894 | $8.36 |
| Q3 2022 | -7,100 | Reduce 7.04% | 93,794 | $6.89 |
| Q4 2022 | -20,216 | Reduce 21.55% | 73,578 | $6.28 |
| Q1 2023 | -29,331 | Reduce 39.86% | 44,247 | $8.10 |
| Q2 2023 | -44,247 | Sold Out | 44,247 | $0.00 |
| Q4 2024 | +66,152 | New Buy | 66,152 | $8.06 |
| Q1 2025 | +36,290 | Add 54.86% | 102,442 | $6.47 |
| Q2 2025 | -26,984 | Reduce 26.34% | 75,458 | $6.66 |
| Q3 2025 | -18,434 | Reduce 24.43% | 57,024 | $6.45 |
Joel Greenblatt's Bausch Health Companies Investment FAQs
Joel Greenblatt first purchased Bausch Health Companies Inc. (BHC) in Q3 2018, acquiring 7,956 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Bausch Health Companies Inc. (BHC) for 29 quarters since Q3 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Bausch Health Companies Inc. (BHC) was in Q2 2019, adding 231,778 shares worth $5.84 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 57,024 shares of Bausch Health Companies Inc. (BHC), valued at approximately $367,805. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bausch Health Companies Inc. (BHC) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Bausch Health Companies Inc. (BHC) was 231,778 shares, as reported at the end of Q2 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.